Adjuvant immunotherapy in node-negative patients: results of a Scandinavian study.
Nissen-Meyer
R
R
Host
H
H
Kjellgren
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D003352:Corynebacterium / Q000276:immunology; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D008198:Lymph Nodes / Q000473:pathology*; D008408:Mastectomy; D008727:Methotrexate / Q000008:administration & dosage; D009664:Norway; D016032:Randomized Controlled Trials as Topic; D013548:Sweden
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate